On 24 January 2014
Glenmark Pharmaceuticals announced that the directors in the board meeting held on 24 January 2014 have allotted 57,600 shares to employees of the company on exercise of options granted to them pursuant to ESOS 2003.Powered by Capital Market - Live News
